09:14 AM EDT, 04/01/2026 (MT Newswires) -- Health care stocks were advancing pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) 0.1% higher and the iShares Biotechnology ETF (IBB) up 0.6%.

Nuvation Bio ( NUVB ) shares were up more than 4% after the company said it has amended its license agreement with Daiichi Sankyo to include Japan rights for safusidenib, giving the company exclusive global development and commercialization control.

Ocugen ( OCGN ) stock was up more than 1% after the company said it completed patient enrollment and dosing for a phase 2/3 trial of OCU410ST in all Stargardt disease indications in less than nine months, earlier than scheduled.

GSK (GSK) and Japan's Shionogi said the latter has completed its acquisition of 11.7% stake in ViiV Healthcare from Pfizer ( PFE ) for about $2.13 billion. GSK shares were 0.9% higher premarket.